Skip to main content
. Author manuscript; available in PMC: 2020 May 2.
Published in final edited form as: Pancreatology. 2019 Nov 21;20(1):101–109. doi: 10.1016/j.pan.2019.11.011

Table 1B—

Cohort II dose escalation (all cycles)

Dose level Erlotinib (mg/day)* Vismodegib (mg/day) Gemcitabine (mg/m2/day)*
−2 75 150 600
−1 75 150 750
1 75 150 1000
2 100 150 750
3 100 150 1000
*

As assigned by the Registration office upon enrollment

Cycle 1 length = 28 days

Erlotinib and Vismodegib taken orally daily throughout each cycle; gemcitabine administered on days 1, 8 and 15, followed by 1 week of rest